nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2C8—Tazarotene—psoriasis	0.102	0.145	CbGbCtD
Thioridazine—CYP1A2—Clobetasol propionate—psoriasis	0.0966	0.138	CbGbCtD
Thioridazine—CYP1A2—Methoxsalen—psoriasis	0.0508	0.0724	CbGbCtD
Thioridazine—CYP2D6—Hydroxyurea—psoriasis	0.0457	0.0652	CbGbCtD
Thioridazine—CYP2C8—Cholecalciferol—psoriasis	0.0434	0.0619	CbGbCtD
Thioridazine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0377	0.0537	CbGbCtD
Thioridazine—CYP2C19—Cholecalciferol—psoriasis	0.0364	0.052	CbGbCtD
Thioridazine—CYP2C9—Cholecalciferol—psoriasis	0.0303	0.0432	CbGbCtD
Thioridazine—CYP2C8—Hydrocortisone—psoriasis	0.0302	0.0431	CbGbCtD
Thioridazine—CYP2C8—Cyclosporine—psoriasis	0.0285	0.0407	CbGbCtD
Thioridazine—CYP2D6—Cholecalciferol—psoriasis	0.0277	0.0395	CbGbCtD
Thioridazine—CYP2C19—Prednisone—psoriasis	0.0253	0.036	CbGbCtD
Thioridazine—CYP2E1—Dexamethasone—psoriasis	0.0252	0.0359	CbGbCtD
Thioridazine—CYP2C19—Cyclosporine—psoriasis	0.0239	0.0341	CbGbCtD
Thioridazine—CYP2C9—Cyclosporine—psoriasis	0.0199	0.0284	CbGbCtD
Thioridazine—CYP2C8—Dexamethasone—psoriasis	0.0188	0.0268	CbGbCtD
Thioridazine—CYP2D6—Cyclosporine—psoriasis	0.0182	0.026	CbGbCtD
Thioridazine—CYP2C19—Dexamethasone—psoriasis	0.0158	0.0225	CbGbCtD
Thioridazine—CYP2C9—Dexamethasone—psoriasis	0.0131	0.0187	CbGbCtD
Thioridazine—CYP2D6—Dexamethasone—psoriasis	0.012	0.0171	CbGbCtD
Thioridazine—Anorexia—Hydroxyurea—psoriasis	0.000455	0.00194	CcSEcCtD
Thioridazine—Anaemia—Mycophenolic acid—psoriasis	0.000453	0.00193	CcSEcCtD
Thioridazine—Agitation—Mycophenolic acid—psoriasis	0.00045	0.00192	CcSEcCtD
Thioridazine—Gynaecomastia—Methotrexate—psoriasis	0.000448	0.00191	CcSEcCtD
Thioridazine—Hypersensitivity—Acitretin—psoriasis	0.000448	0.00191	CcSEcCtD
Thioridazine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000447	0.00191	CcSEcCtD
Thioridazine—Lethargy—Prednisone—psoriasis	0.000444	0.00189	CcSEcCtD
Thioridazine—Leukopenia—Mycophenolic acid—psoriasis	0.000439	0.00187	CcSEcCtD
Thioridazine—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.000438	0.00187	CcSEcCtD
Thioridazine—Vomiting—Calcitriol—psoriasis	0.000435	0.00185	CcSEcCtD
Thioridazine—Weight increased—Triamcinolone—psoriasis	0.000433	0.00185	CcSEcCtD
Thioridazine—Rash—Calcitriol—psoriasis	0.000431	0.00184	CcSEcCtD
Thioridazine—Dermatitis—Calcitriol—psoriasis	0.000431	0.00184	CcSEcCtD
Thioridazine—Headache—Calcitriol—psoriasis	0.000428	0.00183	CcSEcCtD
Thioridazine—Psychotic disorder—Prednisone—psoriasis	0.000425	0.00181	CcSEcCtD
Thioridazine—Somnolence—Hydroxyurea—psoriasis	0.000425	0.00181	CcSEcCtD
Thioridazine—Sweating increased—Betamethasone—psoriasis	0.000421	0.00179	CcSEcCtD
Thioridazine—Sweating increased—Dexamethasone—psoriasis	0.000421	0.00179	CcSEcCtD
Thioridazine—Diarrhoea—Acitretin—psoriasis	0.000416	0.00177	CcSEcCtD
Thioridazine—Decreased appetite—Hydroxyurea—psoriasis	0.000415	0.00177	CcSEcCtD
Thioridazine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000415	0.00177	CcSEcCtD
Thioridazine—Photosensitivity—Methotrexate—psoriasis	0.000414	0.00177	CcSEcCtD
Thioridazine—Cardiac arrest—Prednisone—psoriasis	0.000414	0.00177	CcSEcCtD
Thioridazine—Constipation—Hydroxyurea—psoriasis	0.000408	0.00174	CcSEcCtD
Thioridazine—Arrhythmia—Cyclosporine—psoriasis	0.000407	0.00173	CcSEcCtD
Thioridazine—Nausea—Calcitriol—psoriasis	0.000406	0.00173	CcSEcCtD
Thioridazine—Confusional state—Mycophenolic acid—psoriasis	0.000403	0.00172	CcSEcCtD
Thioridazine—Oedema—Mycophenolic acid—psoriasis	0.0004	0.00171	CcSEcCtD
Thioridazine—Mental disorder—Cyclosporine—psoriasis	0.000399	0.0017	CcSEcCtD
Thioridazine—Arrhythmia—Mycophenolate mofetil—psoriasis	0.000397	0.00169	CcSEcCtD
Thioridazine—Feeling abnormal—Hydroxyurea—psoriasis	0.000394	0.00168	CcSEcCtD
Thioridazine—Weight increased—Dexamethasone—psoriasis	0.000393	0.00168	CcSEcCtD
Thioridazine—Weight increased—Betamethasone—psoriasis	0.000393	0.00168	CcSEcCtD
Thioridazine—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000392	0.00167	CcSEcCtD
Thioridazine—Tachycardia—Mycophenolic acid—psoriasis	0.00039	0.00166	CcSEcCtD
Thioridazine—Mental disorder—Mycophenolate mofetil—psoriasis	0.000389	0.00166	CcSEcCtD
Thioridazine—Vomiting—Acitretin—psoriasis	0.000387	0.00165	CcSEcCtD
Thioridazine—Hyperhidrosis—Mycophenolic acid—psoriasis	0.000387	0.00165	CcSEcCtD
Thioridazine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000386	0.00164	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Methotrexate—psoriasis	0.000386	0.00164	CcSEcCtD
Thioridazine—Rash—Acitretin—psoriasis	0.000384	0.00164	CcSEcCtD
Thioridazine—Dermatitis—Acitretin—psoriasis	0.000383	0.00163	CcSEcCtD
Thioridazine—Rash—Fluocinolone Acetonide—psoriasis	0.000382	0.00163	CcSEcCtD
Thioridazine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000382	0.00163	CcSEcCtD
Thioridazine—Anorexia—Mycophenolic acid—psoriasis	0.000381	0.00163	CcSEcCtD
Thioridazine—Headache—Acitretin—psoriasis	0.000381	0.00162	CcSEcCtD
Thioridazine—Headache—Fluocinolone Acetonide—psoriasis	0.00038	0.00162	CcSEcCtD
Thioridazine—Body temperature increased—Hydroxyurea—psoriasis	0.000378	0.00161	CcSEcCtD
Thioridazine—Hypotension—Mycophenolic acid—psoriasis	0.000374	0.00159	CcSEcCtD
Thioridazine—Vision blurred—Cyclosporine—psoriasis	0.000374	0.00159	CcSEcCtD
Thioridazine—Tremor—Cyclosporine—psoriasis	0.000371	0.00158	CcSEcCtD
Thioridazine—Lethargy—Methotrexate—psoriasis	0.000371	0.00158	CcSEcCtD
Thioridazine—Arrhythmia—Prednisolone—psoriasis	0.00037	0.00158	CcSEcCtD
Thioridazine—Sweating increased—Prednisone—psoriasis	0.000367	0.00156	CcSEcCtD
Thioridazine—Anaemia—Cyclosporine—psoriasis	0.000366	0.00156	CcSEcCtD
Thioridazine—Agitation—Cyclosporine—psoriasis	0.000364	0.00155	CcSEcCtD
Thioridazine—Tremor—Mycophenolate mofetil—psoriasis	0.000362	0.00155	CcSEcCtD
Thioridazine—Angioedema—Cyclosporine—psoriasis	0.000362	0.00154	CcSEcCtD
Thioridazine—Arrhythmia—Hydrocortisone—psoriasis	0.000362	0.00154	CcSEcCtD
Thioridazine—Nausea—Acitretin—psoriasis	0.000361	0.00154	CcSEcCtD
Thioridazine—Erythema—Prednisolone—psoriasis	0.000361	0.00154	CcSEcCtD
Thioridazine—Nausea—Fluocinolone Acetonide—psoriasis	0.00036	0.00154	CcSEcCtD
Thioridazine—Anaemia—Mycophenolate mofetil—psoriasis	0.000357	0.00152	CcSEcCtD
Thioridazine—Somnolence—Mycophenolic acid—psoriasis	0.000356	0.00152	CcSEcCtD
Thioridazine—Agitation—Mycophenolate mofetil—psoriasis	0.000355	0.00152	CcSEcCtD
Thioridazine—Leukopenia—Cyclosporine—psoriasis	0.000355	0.00151	CcSEcCtD
Thioridazine—Mental disorder—Hydrocortisone—psoriasis	0.000355	0.00151	CcSEcCtD
Thioridazine—Angioedema—Mycophenolate mofetil—psoriasis	0.000353	0.00151	CcSEcCtD
Thioridazine—Erythema—Hydrocortisone—psoriasis	0.000352	0.0015	CcSEcCtD
Thioridazine—Hypersensitivity—Hydroxyurea—psoriasis	0.000352	0.0015	CcSEcCtD
Thioridazine—Decreased appetite—Mycophenolic acid—psoriasis	0.000348	0.00148	CcSEcCtD
Thioridazine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000346	0.00148	CcSEcCtD
Thioridazine—Weight increased—Prednisone—psoriasis	0.000342	0.00146	CcSEcCtD
Thioridazine—Constipation—Mycophenolic acid—psoriasis	0.000342	0.00146	CcSEcCtD
Thioridazine—Arrhythmia—Triamcinolone—psoriasis	0.00034	0.00145	CcSEcCtD
Thioridazine—Vision blurred—Prednisolone—psoriasis	0.00034	0.00145	CcSEcCtD
Thioridazine—Erythema—Triamcinolone—psoriasis	0.000332	0.00141	CcSEcCtD
Thioridazine—Angioedema—Prednisolone—psoriasis	0.00033	0.00141	CcSEcCtD
Thioridazine—Feeling abnormal—Mycophenolic acid—psoriasis	0.00033	0.00141	CcSEcCtD
Thioridazine—Diarrhoea—Hydroxyurea—psoriasis	0.000327	0.00139	CcSEcCtD
Thioridazine—Confusional state—Cyclosporine—psoriasis	0.000326	0.00139	CcSEcCtD
Thioridazine—Oedema—Cyclosporine—psoriasis	0.000324	0.00138	CcSEcCtD
Thioridazine—Angioedema—Hydrocortisone—psoriasis	0.000322	0.00137	CcSEcCtD
Thioridazine—Confusional state—Mycophenolate mofetil—psoriasis	0.000318	0.00136	CcSEcCtD
Thioridazine—Thrombocytopenia—Cyclosporine—psoriasis	0.000317	0.00135	CcSEcCtD
Thioridazine—Body temperature increased—Mycophenolic acid—psoriasis	0.000316	0.00135	CcSEcCtD
Thioridazine—Oedema—Mycophenolate mofetil—psoriasis	0.000316	0.00135	CcSEcCtD
Thioridazine—Asthma—Methotrexate—psoriasis	0.000314	0.00134	CcSEcCtD
Thioridazine—Hyperhidrosis—Cyclosporine—psoriasis	0.000313	0.00133	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—psoriasis	0.000311	0.00133	CcSEcCtD
Thioridazine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000309	0.00132	CcSEcCtD
Thioridazine—Arrhythmia—Dexamethasone—psoriasis	0.000309	0.00132	CcSEcCtD
Thioridazine—Arrhythmia—Betamethasone—psoriasis	0.000309	0.00132	CcSEcCtD
Thioridazine—Anorexia—Cyclosporine—psoriasis	0.000308	0.00132	CcSEcCtD
Thioridazine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000308	0.00131	CcSEcCtD
Thioridazine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000305	0.0013	CcSEcCtD
Thioridazine—Vomiting—Hydroxyurea—psoriasis	0.000304	0.00129	CcSEcCtD
Thioridazine—Angioedema—Triamcinolone—psoriasis	0.000303	0.00129	CcSEcCtD
Thioridazine—Rash—Hydroxyurea—psoriasis	0.000301	0.00128	CcSEcCtD
Thioridazine—Erythema—Betamethasone—psoriasis	0.000301	0.00128	CcSEcCtD
Thioridazine—Erythema—Dexamethasone—psoriasis	0.000301	0.00128	CcSEcCtD
Thioridazine—Anorexia—Mycophenolate mofetil—psoriasis	0.000301	0.00128	CcSEcCtD
Thioridazine—Dermatitis—Hydroxyurea—psoriasis	0.000301	0.00128	CcSEcCtD
Thioridazine—Headache—Hydroxyurea—psoriasis	0.000299	0.00128	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—psoriasis	0.000299	0.00127	CcSEcCtD
Thioridazine—Hypotension—Mycophenolate mofetil—psoriasis	0.000295	0.00126	CcSEcCtD
Thioridazine—Oedema—Prednisolone—psoriasis	0.000294	0.00126	CcSEcCtD
Thioridazine—Somnolence—Cyclosporine—psoriasis	0.000288	0.00123	CcSEcCtD
Thioridazine—Oedema—Hydrocortisone—psoriasis	0.000288	0.00123	CcSEcCtD
Thioridazine—Tachycardia—Prednisolone—psoriasis	0.000287	0.00123	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—psoriasis	0.000287	0.00122	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisolone—psoriasis	0.000285	0.00121	CcSEcCtD
Thioridazine—Nausea—Hydroxyurea—psoriasis	0.000284	0.00121	CcSEcCtD
Thioridazine—Decreased appetite—Cyclosporine—psoriasis	0.000281	0.0012	CcSEcCtD
Thioridazine—Tachycardia—Hydrocortisone—psoriasis	0.000281	0.0012	CcSEcCtD
Thioridazine—Somnolence—Mycophenolate mofetil—psoriasis	0.000281	0.0012	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—psoriasis	0.00028	0.0012	CcSEcCtD
Thioridazine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000278	0.00119	CcSEcCtD
Thioridazine—Constipation—Cyclosporine—psoriasis	0.000277	0.00118	CcSEcCtD
Thioridazine—Angioedema—Betamethasone—psoriasis	0.000275	0.00117	CcSEcCtD
Thioridazine—Angioedema—Dexamethasone—psoriasis	0.000275	0.00117	CcSEcCtD
Thioridazine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000274	0.00117	CcSEcCtD
Thioridazine—Anorexia—Hydrocortisone—psoriasis	0.000274	0.00117	CcSEcCtD
Thioridazine—Diarrhoea—Mycophenolic acid—psoriasis	0.000274	0.00117	CcSEcCtD
Thioridazine—Oedema—Triamcinolone—psoriasis	0.000271	0.00115	CcSEcCtD
Thioridazine—Constipation—Mycophenolate mofetil—psoriasis	0.00027	0.00115	CcSEcCtD
Thioridazine—Arrhythmia—Prednisone—psoriasis	0.000269	0.00115	CcSEcCtD
Thioridazine—Hypotension—Hydrocortisone—psoriasis	0.000269	0.00115	CcSEcCtD
Thioridazine—Feeling abnormal—Cyclosporine—psoriasis	0.000267	0.00114	CcSEcCtD
Thioridazine—Tachycardia—Triamcinolone—psoriasis	0.000264	0.00113	CcSEcCtD
Thioridazine—Mental disorder—Prednisone—psoriasis	0.000264	0.00113	CcSEcCtD
Thioridazine—Erythema—Prednisone—psoriasis	0.000262	0.00112	CcSEcCtD
Thioridazine—Hyperhidrosis—Triamcinolone—psoriasis	0.000262	0.00112	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—psoriasis	0.000262	0.00112	CcSEcCtD
Thioridazine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00026	0.00111	CcSEcCtD
Thioridazine—Body temperature increased—Cyclosporine—psoriasis	0.000256	0.00109	CcSEcCtD
Thioridazine—Vomiting—Mycophenolic acid—psoriasis	0.000254	0.00108	CcSEcCtD
Thioridazine—Rash—Mycophenolic acid—psoriasis	0.000252	0.00108	CcSEcCtD
Thioridazine—Dermatitis—Mycophenolic acid—psoriasis	0.000252	0.00107	CcSEcCtD
Thioridazine—Headache—Mycophenolic acid—psoriasis	0.000251	0.00107	CcSEcCtD
Thioridazine—Decreased appetite—Hydrocortisone—psoriasis	0.00025	0.00107	CcSEcCtD
Thioridazine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.00025	0.00106	CcSEcCtD
Thioridazine—Vision blurred—Prednisone—psoriasis	0.000247	0.00105	CcSEcCtD
Thioridazine—Oedema—Betamethasone—psoriasis	0.000246	0.00105	CcSEcCtD
Thioridazine—Oedema—Dexamethasone—psoriasis	0.000246	0.00105	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisolone—psoriasis	0.000243	0.00103	CcSEcCtD
Thioridazine—Anaemia—Prednisone—psoriasis	0.000242	0.00103	CcSEcCtD
Thioridazine—Agitation—Prednisone—psoriasis	0.000241	0.00103	CcSEcCtD
Thioridazine—Thrombocytopenia—Betamethasone—psoriasis	0.000241	0.00103	CcSEcCtD
Thioridazine—Thrombocytopenia—Dexamethasone—psoriasis	0.000241	0.00103	CcSEcCtD
Thioridazine—Tachycardia—Dexamethasone—psoriasis	0.00024	0.00102	CcSEcCtD
Thioridazine—Tachycardia—Betamethasone—psoriasis	0.00024	0.00102	CcSEcCtD
Thioridazine—Angioedema—Prednisone—psoriasis	0.00024	0.00102	CcSEcCtD
Thioridazine—Hypersensitivity—Cyclosporine—psoriasis	0.000238	0.00102	CcSEcCtD
Thioridazine—Nausea—Mycophenolic acid—psoriasis	0.000238	0.00101	CcSEcCtD
Thioridazine—Hyperhidrosis—Dexamethasone—psoriasis	0.000238	0.00101	CcSEcCtD
Thioridazine—Hyperhidrosis—Betamethasone—psoriasis	0.000238	0.00101	CcSEcCtD
Thioridazine—Feeling abnormal—Hydrocortisone—psoriasis	0.000237	0.00101	CcSEcCtD
Thioridazine—Anorexia—Betamethasone—psoriasis	0.000234	0.000999	CcSEcCtD
Thioridazine—Anorexia—Dexamethasone—psoriasis	0.000234	0.000999	CcSEcCtD
Thioridazine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000233	0.000992	CcSEcCtD
Thioridazine—Hypotension—Dexamethasone—psoriasis	0.00023	0.000979	CcSEcCtD
Thioridazine—Hypotension—Betamethasone—psoriasis	0.00023	0.000979	CcSEcCtD
Thioridazine—Body temperature increased—Hydrocortisone—psoriasis	0.000227	0.000969	CcSEcCtD
Thioridazine—Feeling abnormal—Triamcinolone—psoriasis	0.000223	0.000951	CcSEcCtD
Thioridazine—Diarrhoea—Cyclosporine—psoriasis	0.000221	0.000944	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—psoriasis	0.000221	0.00094	CcSEcCtD
Thioridazine—Erythema—Methotrexate—psoriasis	0.000219	0.000934	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisolone—psoriasis	0.000217	0.000925	CcSEcCtD
Thioridazine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000216	0.000921	CcSEcCtD
Thioridazine—Body temperature increased—Triamcinolone—psoriasis	0.000214	0.000913	CcSEcCtD
Thioridazine—Oedema—Prednisone—psoriasis	0.000214	0.000912	CcSEcCtD
Thioridazine—Decreased appetite—Betamethasone—psoriasis	0.000214	0.000911	CcSEcCtD
Thioridazine—Decreased appetite—Dexamethasone—psoriasis	0.000214	0.000911	CcSEcCtD
Thioridazine—Hypersensitivity—Hydrocortisone—psoriasis	0.000212	0.000903	CcSEcCtD
Thioridazine—Tachycardia—Prednisone—psoriasis	0.000209	0.00089	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisone—psoriasis	0.000207	0.000882	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—psoriasis	0.000206	0.00088	CcSEcCtD
Thioridazine—Vomiting—Cyclosporine—psoriasis	0.000206	0.000877	CcSEcCtD
Thioridazine—Rash—Cyclosporine—psoriasis	0.000204	0.00087	CcSEcCtD
Thioridazine—Anorexia—Prednisone—psoriasis	0.000204	0.00087	CcSEcCtD
Thioridazine—Dermatitis—Cyclosporine—psoriasis	0.000204	0.000869	CcSEcCtD
Thioridazine—Headache—Cyclosporine—psoriasis	0.000203	0.000864	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—psoriasis	0.000203	0.000863	CcSEcCtD
Thioridazine—Feeling abnormal—Dexamethasone—psoriasis	0.000202	0.000863	CcSEcCtD
Thioridazine—Feeling abnormal—Betamethasone—psoriasis	0.000202	0.000863	CcSEcCtD
Thioridazine—Vomiting—Mycophenolate mofetil—psoriasis	0.000201	0.000856	CcSEcCtD
Thioridazine—Hypersensitivity—Triamcinolone—psoriasis	0.0002	0.000851	CcSEcCtD
Thioridazine—Rash—Mycophenolate mofetil—psoriasis	0.000199	0.000849	CcSEcCtD
Thioridazine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000199	0.000848	CcSEcCtD
Thioridazine—Headache—Mycophenolate mofetil—psoriasis	0.000198	0.000843	CcSEcCtD
Thioridazine—Diarrhoea—Hydrocortisone—psoriasis	0.000197	0.000839	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—psoriasis	0.000196	0.000836	CcSEcCtD
Thioridazine—Body temperature increased—Dexamethasone—psoriasis	0.000194	0.000828	CcSEcCtD
Thioridazine—Body temperature increased—Betamethasone—psoriasis	0.000194	0.000828	CcSEcCtD
Thioridazine—Nausea—Cyclosporine—psoriasis	0.000192	0.00082	CcSEcCtD
Thioridazine—Nausea—Mycophenolate mofetil—psoriasis	0.000188	0.000799	CcSEcCtD
Thioridazine—Decreased appetite—Prednisone—psoriasis	0.000186	0.000793	CcSEcCtD
Thioridazine—Rash—Prednisolone—psoriasis	0.000186	0.000792	CcSEcCtD
Thioridazine—Dermatitis—Prednisolone—psoriasis	0.000185	0.000791	CcSEcCtD
Thioridazine—Headache—Prednisolone—psoriasis	0.000184	0.000787	CcSEcCtD
Thioridazine—Constipation—Prednisone—psoriasis	0.000183	0.00078	CcSEcCtD
Thioridazine—Vomiting—Hydrocortisone—psoriasis	0.000183	0.00078	CcSEcCtD
Thioridazine—Rash—Hydrocortisone—psoriasis	0.000181	0.000773	CcSEcCtD
Thioridazine—Dermatitis—Hydrocortisone—psoriasis	0.000181	0.000772	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—psoriasis	0.00018	0.000769	CcSEcCtD
Thioridazine—Headache—Hydrocortisone—psoriasis	0.00018	0.000768	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisone—psoriasis	0.000176	0.000752	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—psoriasis	0.000175	0.000747	CcSEcCtD
Thioridazine—Nausea—Prednisolone—psoriasis	0.000175	0.000746	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—psoriasis	0.000173	0.000737	CcSEcCtD
Thioridazine—Vomiting—Triamcinolone—psoriasis	0.000172	0.000734	CcSEcCtD
Thioridazine—Nausea—Hydrocortisone—psoriasis	0.000171	0.000728	CcSEcCtD
Thioridazine—Rash—Triamcinolone—psoriasis	0.000171	0.000728	CcSEcCtD
Thioridazine—Dermatitis—Triamcinolone—psoriasis	0.000171	0.000727	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—psoriasis	0.00017	0.000727	CcSEcCtD
Thioridazine—Headache—Triamcinolone—psoriasis	0.00017	0.000723	CcSEcCtD
Thioridazine—Body temperature increased—Prednisone—psoriasis	0.000169	0.000721	CcSEcCtD
Thioridazine—Diarrhoea—Dexamethasone—psoriasis	0.000168	0.000717	CcSEcCtD
Thioridazine—Diarrhoea—Betamethasone—psoriasis	0.000168	0.000717	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—psoriasis	0.000167	0.000712	CcSEcCtD
Thioridazine—Nausea—Triamcinolone—psoriasis	0.000161	0.000686	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—psoriasis	0.000159	0.000678	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisone—psoriasis	0.000158	0.000672	CcSEcCtD
Thioridazine—Vomiting—Dexamethasone—psoriasis	0.000156	0.000666	CcSEcCtD
Thioridazine—Vomiting—Betamethasone—psoriasis	0.000156	0.000666	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—psoriasis	0.000155	0.000663	CcSEcCtD
Thioridazine—Rash—Betamethasone—psoriasis	0.000155	0.000661	CcSEcCtD
Thioridazine—Rash—Dexamethasone—psoriasis	0.000155	0.000661	CcSEcCtD
Thioridazine—Dermatitis—Betamethasone—psoriasis	0.000155	0.00066	CcSEcCtD
Thioridazine—Dermatitis—Dexamethasone—psoriasis	0.000155	0.00066	CcSEcCtD
Thioridazine—Headache—Betamethasone—psoriasis	0.000154	0.000656	CcSEcCtD
Thioridazine—Headache—Dexamethasone—psoriasis	0.000154	0.000656	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—psoriasis	0.000147	0.000628	CcSEcCtD
Thioridazine—Diarrhoea—Prednisone—psoriasis	0.000146	0.000624	CcSEcCtD
Thioridazine—Nausea—Dexamethasone—psoriasis	0.000146	0.000622	CcSEcCtD
Thioridazine—Nausea—Betamethasone—psoriasis	0.000146	0.000622	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—psoriasis	0.000141	0.000603	CcSEcCtD
Thioridazine—Vomiting—Prednisone—psoriasis	0.000136	0.00058	CcSEcCtD
Thioridazine—Rash—Prednisone—psoriasis	0.000135	0.000575	CcSEcCtD
Thioridazine—Dermatitis—Prednisone—psoriasis	0.000135	0.000575	CcSEcCtD
Thioridazine—Headache—Prednisone—psoriasis	0.000134	0.000572	CcSEcCtD
Thioridazine—Hypersensitivity—Methotrexate—psoriasis	0.000132	0.000562	CcSEcCtD
Thioridazine—Nausea—Prednisone—psoriasis	0.000127	0.000542	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—psoriasis	0.000122	0.000522	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—psoriasis	0.000114	0.000485	CcSEcCtD
Thioridazine—Rash—Methotrexate—psoriasis	0.000113	0.000481	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—psoriasis	0.000113	0.00048	CcSEcCtD
Thioridazine—Headache—Methotrexate—psoriasis	0.000112	0.000478	CcSEcCtD
Thioridazine—Nausea—Methotrexate—psoriasis	0.000106	0.000453	CcSEcCtD
Thioridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.84e-05	0.000443	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCL20—psoriasis	2.82e-05	0.000441	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—NOS2—psoriasis	2.82e-05	0.000441	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL20—psoriasis	2.78e-05	0.000434	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL20—psoriasis	2.77e-05	0.000433	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—CXCL8—psoriasis	2.73e-05	0.000426	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL20—psoriasis	2.73e-05	0.000426	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL20—psoriasis	2.72e-05	0.000425	CbGpPWpGaD
Thioridazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.72e-05	0.000424	CbGpPWpGaD
Thioridazine—DRD2—Circadian rythm related genes—IL6—psoriasis	2.64e-05	0.000413	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CARM1—psoriasis	2.57e-05	0.000401	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL20—psoriasis	2.53e-05	0.000395	CbGpPWpGaD
Thioridazine—DRD2—GPCR ligand binding—CXCL8—psoriasis	2.51e-05	0.000393	CbGpPWpGaD
Thioridazine—HTR2A—GPCR ligand binding—CXCL8—psoriasis	2.47e-05	0.000387	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—CXCL8—psoriasis	2.47e-05	0.000386	CbGpPWpGaD
Thioridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.46e-05	0.000385	CbGpPWpGaD
Thioridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.46e-05	0.000384	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—CXCL8—psoriasis	2.43e-05	0.000379	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—CXCL8—psoriasis	2.42e-05	0.000378	CbGpPWpGaD
Thioridazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.41e-05	0.000377	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—SOCS1—psoriasis	2.39e-05	0.000374	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—SOCS1—psoriasis	2.39e-05	0.000373	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CARM1—psoriasis	2.36e-05	0.000369	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—TYK2—psoriasis	2.28e-05	0.000356	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—TYK2—psoriasis	2.28e-05	0.000356	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	2.25e-05	0.000352	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.19e-05	0.000342	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—CXCL8—psoriasis	2.19e-05	0.000342	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—CXCL8—psoriasis	2.18e-05	0.000341	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SOCS1—psoriasis	2.06e-05	0.000322	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CARM1—psoriasis	2.04e-05	0.000319	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—CXCL8—psoriasis	1.99e-05	0.00031	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—CXCL8—psoriasis	1.98e-05	0.00031	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—TYK2—psoriasis	1.96e-05	0.000307	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.95e-05	0.000305	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.91e-05	0.000298	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—CXCL8—psoriasis	1.88e-05	0.000294	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CARM1—psoriasis	1.82e-05	0.000284	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.78e-05	0.000278	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SOCS1—psoriasis	1.77e-05	0.000277	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—LEP—psoriasis	1.76e-05	0.000276	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—APOE—psoriasis	1.76e-05	0.000276	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—LEP—psoriasis	1.76e-05	0.000275	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—APOE—psoriasis	1.76e-05	0.000275	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SOCS1—psoriasis	1.76e-05	0.000275	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—CXCL8—psoriasis	1.71e-05	0.000267	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.7e-05	0.000266	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.69e-05	0.000264	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SOCS1—psoriasis	1.69e-05	0.000263	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.68e-05	0.000262	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CARM1—psoriasis	1.67e-05	0.000262	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CARM1—psoriasis	1.66e-05	0.000259	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—NFKBIA—psoriasis	1.64e-05	0.000257	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—NFKBIA—psoriasis	1.64e-05	0.000257	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—VEGFA—psoriasis	1.63e-05	0.000255	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.62e-05	0.000253	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.61e-05	0.000252	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—TYK2—psoriasis	1.61e-05	0.000251	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CAT—psoriasis	1.58e-05	0.000247	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SOCS1—psoriasis	1.55e-05	0.000243	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.55e-05	0.000242	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	1.54e-05	0.000241	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.53e-05	0.000239	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SOCS1—psoriasis	1.53e-05	0.000238	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.52e-05	0.000238	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—LEP—psoriasis	1.52e-05	0.000237	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—APOE—psoriasis	1.52e-05	0.000237	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SOCS1—psoriasis	1.5e-05	0.000235	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.5e-05	0.000234	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—TYK2—psoriasis	1.48e-05	0.000232	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.47e-05	0.00023	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.46e-05	0.000228	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.46e-05	0.000228	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—TYK2—psoriasis	1.46e-05	0.000227	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CAT—psoriasis	1.45e-05	0.000227	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—TYK2—psoriasis	1.43e-05	0.000224	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.43e-05	0.000223	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.42e-05	0.000222	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CARM1—psoriasis	1.42e-05	0.000222	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NFKBIA—psoriasis	1.42e-05	0.000221	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.4e-05	0.000219	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.4e-05	0.000218	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.4e-05	0.000218	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.39e-05	0.000217	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	1.37e-05	0.000214	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.37e-05	0.000214	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TYK2—psoriasis	1.35e-05	0.00021	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TYK2—psoriasis	1.35e-05	0.00021	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.33e-05	0.000207	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.33e-05	0.000207	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—LEP—psoriasis	1.31e-05	0.000204	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—APOE—psoriasis	1.31e-05	0.000204	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—APOE—psoriasis	1.3e-05	0.000203	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—LEP—psoriasis	1.3e-05	0.000203	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.29e-05	0.000202	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.27e-05	0.000199	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.27e-05	0.000198	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.27e-05	0.000198	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CAT—psoriasis	1.25e-05	0.000196	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	1.25e-05	0.000195	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—LEP—psoriasis	1.24e-05	0.000194	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—APOE—psoriasis	1.24e-05	0.000194	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	1.24e-05	0.000194	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TP53—psoriasis	1.24e-05	0.000193	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—APOE—psoriasis	1.23e-05	0.000192	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.22e-05	0.00019	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.21e-05	0.000189	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CXCL8—psoriasis	1.17e-05	0.000183	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CXCL8—psoriasis	1.17e-05	0.000183	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TYK2—psoriasis	1.16e-05	0.000181	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	1.16e-05	0.000181	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	1.16e-05	0.00018	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—LEP—psoriasis	1.15e-05	0.000179	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—APOE—psoriasis	1.15e-05	0.000179	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—LEP—psoriasis	1.13e-05	0.000176	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—APOE—psoriasis	1.13e-05	0.000176	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—APOE—psoriasis	1.13e-05	0.000176	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—APOE—psoriasis	1.13e-05	0.000176	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—LEP—psoriasis	1.13e-05	0.000176	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CAT—psoriasis	1.12e-05	0.000175	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—IL6—psoriasis	1.12e-05	0.000174	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—IL6—psoriasis	1.11e-05	0.000174	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—LEP—psoriasis	1.11e-05	0.000173	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—APOE—psoriasis	1.11e-05	0.000173	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—LEP—psoriasis	1.11e-05	0.000173	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—APOE—psoriasis	1.11e-05	0.000173	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—JUN—psoriasis	1.09e-05	0.00017	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—JUN—psoriasis	1.09e-05	0.00017	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PPARG—psoriasis	1.07e-05	0.000167	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.07e-05	0.000167	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	1.05e-05	0.000164	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—NFKB1—psoriasis	1.05e-05	0.000164	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NFKBIA—psoriasis	1.05e-05	0.000164	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—NFKB1—psoriasis	1.05e-05	0.000164	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	1.03e-05	0.000161	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CAT—psoriasis	1.03e-05	0.000161	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	1.03e-05	0.000161	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—LEP—psoriasis	1.03e-05	0.00016	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—APOE—psoriasis	1.03e-05	0.00016	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CAT—psoriasis	1.02e-05	0.000159	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CXCL8—psoriasis	1.01e-05	0.000158	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TYK2—psoriasis	9.97e-06	0.000156	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TYK2—psoriasis	9.92e-06	0.000155	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PPARG—psoriasis	9.82e-06	0.000153	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—APOE—psoriasis	9.75e-06	0.000152	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—psoriasis	9.6e-06	0.00015	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	9.57e-06	0.000149	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—VEGFA—psoriasis	9.53e-06	0.000149	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—VEGFA—psoriasis	9.52e-06	0.000149	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TYK2—psoriasis	9.5e-06	0.000148	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—STAT3—psoriasis	9.43e-06	0.000147	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—STAT3—psoriasis	9.42e-06	0.000147	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—JUN—psoriasis	9.39e-06	0.000147	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NFKB1—psoriasis	9.03e-06	0.000141	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TYK2—psoriasis	8.75e-06	0.000137	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CAT—psoriasis	8.72e-06	0.000136	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—APOE—psoriasis	8.7e-06	0.000136	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CXCL8—psoriasis	8.68e-06	0.000136	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CXCL8—psoriasis	8.64e-06	0.000135	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TYK2—psoriasis	8.61e-06	0.000135	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TYK2—psoriasis	8.6e-06	0.000134	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PPARG—psoriasis	8.49e-06	0.000133	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TYK2—psoriasis	8.46e-06	0.000132	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TYK2—psoriasis	8.43e-06	0.000132	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	8.27e-06	0.000129	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—psoriasis	8.26e-06	0.000129	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—psoriasis	8.21e-06	0.000128	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—psoriasis	8.2e-06	0.000128	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—STAT3—psoriasis	8.12e-06	0.000127	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—JUN—psoriasis	8.07e-06	0.000126	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—JUN—psoriasis	8.03e-06	0.000125	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—APOE—psoriasis	8e-06	0.000125	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOE—psoriasis	7.93e-06	0.000124	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—psoriasis	7.86e-06	0.000123	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TYK2—psoriasis	7.84e-06	0.000122	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NFKB1—psoriasis	7.77e-06	0.000121	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NFKB1—psoriasis	7.73e-06	0.000121	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—JUN—psoriasis	7.69e-06	0.00012	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCL8—psoriasis	7.62e-06	0.000119	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARG—psoriasis	7.58e-06	0.000118	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCL8—psoriasis	7.5e-06	0.000117	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCL8—psoriasis	7.48e-06	0.000117	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	7.4e-06	0.000116	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCL8—psoriasis	7.36e-06	0.000115	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	7.34e-06	0.000115	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—psoriasis	7.25e-06	0.000113	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—psoriasis	7.2e-06	0.000112	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—psoriasis	7.19e-06	0.000112	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—psoriasis	7.13e-06	0.000111	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—psoriasis	7.12e-06	0.000111	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—JUN—psoriasis	7.09e-06	0.000111	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—psoriasis	7.05e-06	0.00011	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—psoriasis	7.01e-06	0.00011	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—psoriasis	7e-06	0.000109	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—psoriasis	6.98e-06	0.000109	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—psoriasis	6.98e-06	0.000109	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—JUN—psoriasis	6.97e-06	0.000109	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARG—psoriasis	6.97e-06	0.000109	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—JUN—psoriasis	6.96e-06	0.000109	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—psoriasis	6.95e-06	0.000109	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARG—psoriasis	6.91e-06	0.000108	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—JUN—psoriasis	6.85e-06	0.000107	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—JUN—psoriasis	6.83e-06	0.000107	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	6.82e-06	0.000107	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NFKB1—psoriasis	6.82e-06	0.000107	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOE—psoriasis	6.78e-06	0.000106	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	6.72e-06	0.000105	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NFKB1—psoriasis	6.71e-06	0.000105	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NFKB1—psoriasis	6.7e-06	0.000105	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—psoriasis	6.65e-06	0.000104	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NFKB1—psoriasis	6.59e-06	0.000103	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—psoriasis	6.59e-06	0.000103	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—psoriasis	6.58e-06	0.000103	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	6.57e-06	0.000103	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—psoriasis	6.49e-06	0.000101	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—JUN—psoriasis	6.34e-06	9.91e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—psoriasis	6.2e-06	9.68e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—psoriasis	6.19e-06	9.67e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—psoriasis	6.13e-06	9.58e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	6.11e-06	9.54e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—psoriasis	6.09e-06	9.52e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—psoriasis	6.08e-06	9.5e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—psoriasis	6.03e-06	9.42e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—psoriasis	6.02e-06	9.4e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—psoriasis	5.98e-06	9.34e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	5.96e-06	9.32e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—psoriasis	5.92e-06	9.25e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—psoriasis	5.91e-06	9.23e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARG—psoriasis	5.9e-06	9.22e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—psoriasis	5.67e-06	8.86e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	5.54e-06	8.66e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—psoriasis	5.49e-06	8.57e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—psoriasis	5.33e-06	8.32e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—psoriasis	5.3e-06	8.28e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—psoriasis	5.07e-06	7.93e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—psoriasis	4.88e-06	7.62e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—psoriasis	4.85e-06	7.58e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—psoriasis	4.68e-06	7.31e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—psoriasis	4.64e-06	7.26e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—psoriasis	4.6e-06	7.19e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—psoriasis	4.59e-06	7.18e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—psoriasis	4.52e-06	7.06e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—psoriasis	4.51e-06	7.04e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—psoriasis	4.28e-06	6.69e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—psoriasis	4.21e-06	6.58e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—psoriasis	4.2e-06	6.57e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—psoriasis	4.19e-06	6.54e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—psoriasis	4.14e-06	6.46e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—psoriasis	4.13e-06	6.44e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—psoriasis	3.83e-06	5.99e-05	CbGpPWpGaD
